Lonza

Lonza awarded NIH contract for research grade iPSCs

Monday, February 25, 2013 09:59 AM

The National Institutes of Health Center for Regenerative Medicine (NIH CRM) has awarded Lonza’s Walkersville, Md., facility a contract to generate induced pluripotent stem cells (iPSCs) for research purposes.  The contract is a three year agreement with a value up to $6.9 million dollars.                                      

More... »


AMRI names new president for AMRI Europe

Wednesday, May 23, 2012 12:05 PM

AMRI, a global contract research and manufacturing organization, has appointed Ian Shott as president of AMRI Europe.

More... »


Lonza and Agennix to collaborate on talactoferrin

Monday, April 16, 2012 12:49 PM

Switzerland-based Lonza and Germany-based Agennix have signed an agreement for the production of Agennix’s talactoferrin.

More... »

BioLife Solutions adds to Scientific Advisory Board

Monday, January 23, 2012 12:32 PM

BioLife Solutions, a developer, manufacturer and marketer of proprietary hypothermic storage and cryopreservation freeze media, has added three key opinion leaders in the biobanking, drug discovery and regenerative medicine markets to its Scientific Advisory Board (SAB).

More... »

Cellectis, Lonza reach milestone with CHO-K1SV GS

Friday, July 22, 2011 10:14 AM

Cellectis bioresearch and Lonza have reached a significant milestone in the development of a newly bioengineered cell line.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs